Literature DB >> 24524364

Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection.

Huan Xu1, Feifei Ye, Meina Hu, Pengpeng Yin, Wei Zhang, Yan Li, Xiu Yu, Yihui Deng.   

Abstract

When polyethylene glycol (PEG)ylated liposomes were repeatedly injected into the same animal, the second dose of liposomes would rapidly clear from the bloodstream and enhance accumulation in the liver and spleen, and this phenomenon is called "accelerated blood clearance (ABC)". There are many factors known to influence ABC phenomenon, in this study, we mainly focused on the effects of different phospholipids (PL) types and animal models. The effects of PL types on ABC phenomenon were examined by repeating injection of PEGylated liposomes prepared by five different types of PL (hydrogenated soy phosphatidylcholine, egg sphingomyelin, soybean phosphatidycholin, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine and egg phosphatidycholin) in rats. Dramatically, repeated injection of different types of PL could induce ABC phenomenon altogether. Both t1/2 and AUC of experimental group (EG) were lower significantly than those of control group (CG). Our results also showed that the liver accumulation of second dose increased significantly (p < 0.01) in all EG as compared that of CG. Interestingly, ABC phenomenon of liposomes prepared by unsaturated PL was more obvious than that of saturated PL. All the first dose could induce the antibody (anti-PEG IgM) level increasing significantly (p < 0.01). For different animal models, we found that after repeated injection of PEGylated liposomes, rats, mice, rabbits and guinea pigs could produce ABC phenomenon. Various PL types and animal models could all produce the ABC phenomenon. However, their extent of accelerated clearance differed. ABC phenomenon is possibly a ubiquitous immune phenomenon in life.

Entities:  

Keywords:  Accelerated blood clearance phenomenon; animal models; liposome; phospholipid types; polyethylene glycol

Mesh:

Substances:

Year:  2014        PMID: 24524364     DOI: 10.3109/10717544.2014.885998

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  10 in total

1.  PEGylated lipid microspheres loaded with cabazitaxel for intravenous administration: stability, bioavailability, antitumor efficacy, and toxicity.

Authors:  Yang Liu; Bin Xie; Lin Li; Xinyu Zhang; Yu Zhang; Haibing He; Tian Yin; Xing Tang; Cuifang Cai; Jingxin Gou
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 2.  Anti-PEG immunity: emergence, characteristics, and unaddressed questions.

Authors:  Qi Yang; Samuel K Lai
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-02-23

3.  A higher dose of PEGylated gold nanoparticles reduces the accelerated blood clearance phenomenon effect and induces spleen B lymphocytes in albino mice.

Authors:  Ahmed M Abu-Dief; Mosa Alsehli; Aziz Awaad
Journal:  Histochem Cell Biol       Date:  2022-02-14       Impact factor: 4.304

4.  Microvesicle-camouflaged biomimetic nanoparticles encapsulating a metal-organic framework for targeted rheumatoid arthritis therapy.

Authors:  Yao Wang; Ming Jia; Xiu Zheng; Chenglong Wang; Yun Zhou; Hong Pan; Yan Liu; Ji Lu; Zhiqiang Mei; Chunhong Li
Journal:  J Nanobiotechnology       Date:  2022-06-03       Impact factor: 9.429

5.  Accelerated Clearance of Ultrasound Contrast Agents Containing Polyethylene Glycol is Associated with the Generation of Anti-Polyethylene Glycol Antibodies.

Authors:  Samantha M Fix; A Gloria Nyankima; Morgan D McSweeney; James K Tsuruta; Samuel K Lai; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2018-03-27       Impact factor: 2.998

Review 6.  PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.

Authors:  Jung Soo Suk; Qingguo Xu; Namho Kim; Justin Hanes; Laura M Ensign
Journal:  Adv Drug Deliv Rev       Date:  2015-10-09       Impact factor: 15.470

7.  Cholesterol-PEG comodified poly (N-butyl) cyanoacrylate nanoparticles for brain delivery: in vitro and in vivo evaluations.

Authors:  Xiao Hu; Feifei Yang; Yonghong Liao; Lin Li; Lan Zhang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

8.  Mixed PEGylated surfactant modifying system decrease the accelerated blood clearance phenomenon of nanoemulsions in rats.

Authors:  Yuqing Su; Wenya Tang; Yanzhi Song; Chunling Wang; Qingjing Tian; Xuling Wang; Jingjing Quan; Buoqun Li; Shaoning Wang; Yihui Deng
Journal:  Asian J Pharm Sci       Date:  2016-07-15       Impact factor: 6.598

Review 9.  Immunological and Toxicological Considerations for the Design of Liposomes.

Authors:  Collin T Inglut; Aaron J Sorrin; Thilinie Kuruppu; Shruti Vig; Julia Cicalo; Haroon Ahmad; Huang-Chiao Huang
Journal:  Nanomaterials (Basel)       Date:  2020-01-22       Impact factor: 5.076

Review 10.  Cleavable PEGylation: a strategy for overcoming the "PEG dilemma" in efficient drug delivery.

Authors:  Yan Fang; Jianxiu Xue; Shan Gao; Anqi Lu; Dongjuan Yang; Hong Jiang; Yang He; Kai Shi
Journal:  Drug Deliv       Date:  2017-12       Impact factor: 6.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.